BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8443693)

  • 1. Ipriflavone: new insights into its mechanisms of action on bone remodeling.
    Brandi ML; Gennari C
    Calcif Tissue Int; 1993 Feb; 52(2):151-2. PubMed ID: 8443693
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.
    Notoya K; Taketomi S; Tsuda M
    Calcif Tissue Int; 1993 Jul; 53(1):71. PubMed ID: 8348388
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone.
    Giossi M; Caruso P; Civelli M; Bongrani S
    Calcif Tissue Int; 1996 Jun; 58(6):419-22. PubMed ID: 8661483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.
    Bonucci E; Ballanti P; Martelli A; Mereto E; Brambilla G; Bianco P; Bufalino L
    Calcif Tissue Int; 1992 Apr; 50(4):314-9. PubMed ID: 1571842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in femoral bone mass by ipriflavone alone and in combination with 1 alpha-hydroxyvitamin D3 in growing rats with skeletal unloading.
    Notoya K; Yoshida K; Tsukuda R; Taketomi S; Tsuda M
    Calcif Tissue Int; 1996 Feb; 58(2):88-94. PubMed ID: 8998683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
    Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
    Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.
    Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
    Calcif Tissue Int; 1992; 51 Suppl 1():S3-6. PubMed ID: 1422982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.
    Azria M; Behhar C; Cooper S
    Calcif Tissue Int; 1993 Jan; 52(1):16-20. PubMed ID: 8240482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipriflavone inhibits murine osteoclast formation in vitro.
    Morita I; Sakaguchi K; Kurachi T; Murota S
    Calcif Tissue Int; 1992; 51 Suppl 1():S7-10. PubMed ID: 1422984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipriflavone directly inhibits osteoclastic activity.
    Albanese CV; Cudd A; Argentino L; Zambonin-Zallone A; MacIntyre I
    Biochem Biophys Res Commun; 1994 Mar; 199(2):930-6. PubMed ID: 8135842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
    Miyauchi A; Notoya K; Taketomi S; Takagi Y; Fujii Y; Jinnai K; Takahashi K; Chihara K; Fujita T
    Endocrinology; 1996 Aug; 137(8):3544-50. PubMed ID: 8754785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and bioeffects of Ipriflavone on a human preosteoclastic cell line.
    Benvenuti S; Petilli M; Frediani U; Tanini A; Fiorelli G; Bianchi S; Bernabei PA; Albanese C; Brandi ML
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1084-9. PubMed ID: 7517664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.
    Benvenuti S; Tanini A; Frediani U; Bianchi S; Masi L; Casano R; Bufalino L; Serio M; Brandi ML
    J Bone Miner Res; 1991 Sep; 6(9):987-96. PubMed ID: 1665005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ipriflavone (TC-80) on bone resorption in tissue culture.
    Tsuda M; Kitazaki T; Ito T; Fujita T
    J Bone Miner Res; 1986 Apr; 1(2):207-11. PubMed ID: 3503539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone.
    Tsutsumi N; Kawashima K; Nagata H; Tsuyuki J; Itoh F; Arai N; Kojima M; Ujiie A; Endo H
    Jpn J Pharmacol; 1994 Aug; 65(4):343-9. PubMed ID: 7990272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipriflavone does not alter bone apatite crystal structure in adult male rats.
    Ghezzo C; Civitelli R; Cadel S; Borelli G; Maiorino M; Bufalino L; Bongrani S
    Calcif Tissue Int; 1996 Dec; 59(6):496-9. PubMed ID: 8939778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipriflavone modulates IGF-I but is unable to restore bone in rats.
    Deyhim F; Smith BJ; Soung DY; Juma S; Devareddy L; Arjmandi BH
    Phytother Res; 2005 Feb; 19(2):116-20. PubMed ID: 15852487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipriflavone inhibits the differentiation of RAW 264.7 cells into osteoclasts via Foxo1.
    Sun J; Zhang G; Hu Z
    Minerva Endocrinol; 2019 Dec; 44(4):400-402. PubMed ID: 31738034
    [No Abstract]   [Full Text] [Related]  

  • 19. Histochemical and fine structural study of bone of ipriflavone-treated rats.
    Ozawa H; Nakamura H; Irie K; Irie M
    Calcif Tissue Int; 1992; 51 Suppl 1():S21-6. PubMed ID: 1422980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ipriflavone on growth and blood testosterone level in male rats].
    Guo HJ; Li HM; Wang CY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):170-1. PubMed ID: 21189542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.